University at Buffalo School of Engineering and Applied Sciences

DCS Names Jon Krzos Vice President of Financial Planning and Analysis

Retrieved on: 
Thursday, September 14, 2023

ALEXANDRIA, Va., Sept. 14, 2023 /PRNewswire/ -- DCS Corporation is pleased to announce the appointment of Jon Krzos as Vice President of Financial Planning and Analysis.

Key Points: 
  • ALEXANDRIA, Va., Sept. 14, 2023 /PRNewswire/ -- DCS Corporation is pleased to announce the appointment of Jon Krzos as Vice President of Financial Planning and Analysis.
  • In this new role, Jon will continue to expand his leadership of corporate financial systems and processes within the Finance and Information Technology Departments.
  • Since joining DCS 23 years ago, Jon has played an essential role in all aspects of corporate budgeting and leveraging technology to support financial planning and reporting.
  • "We recently created the DCS Financial Planning & Analysis Department to accommodate our continued growth and we are glad to have Jon at the helm."

The Department of Education's Institute of Education Sciences and the National Science Foundation Announce New AI Institute to Accelerate Learning

Retrieved on: 
Thursday, May 4, 2023

WASHINGTON, May 4, 2023 /PRNewswire/ -- Today, the Department of Education's Institute of Education Sciences (IES) and the National Science Foundation (NSF) awarded approximately $20 million dollars to the University of Illinois, Urbana Champaign to create The Institute for Inclusive and Intelligent Technologies for Education (INVITE). This institute is one of a suite of institutes launched by the federal government as part of a $500 million investment, the largest from the federal government in artificial intelligence (AI) to date.

Key Points: 
  • INVITE will focus on three noncognitive skills linked to effective learning: persistence, academic resilience, and collaboration.
  • This is the second AI institute NSF and IES have funded together as part of the major investment.
  • The University of Buffalo received an award earlier this year to establish the National AI Institute for Exceptional Education .
  • "The National AI Research Institutes are a critical component of our Nation's AI innovation, infrastructure, technology, education, and partnerships ecosystem," said NSF Director Sethuraman Panchanathan.

Gorilla Technology Group Names Lawrence Ng Head of Asia

Retrieved on: 
Wednesday, February 1, 2023

LONDON, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Gorilla Technology Group Inc. (“Gorilla”) (NASDAQ: GRRR), a global provider of AI based edge video analytics, IoT technologies, and cybersecurity, today announced it has hired technology industry veteran Lawrence Ng as Head of Asia.

Key Points: 
  • LONDON, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Gorilla Technology Group Inc. (“Gorilla”) (NASDAQ: GRRR), a global provider of AI based edge video analytics, IoT technologies, and cybersecurity, today announced it has hired technology industry veteran Lawrence Ng as Head of Asia.
  • In addition, Gorilla announced the opening of its new Singapore office, which Ng will lead.
  • Ng brings more than 25 years of experience in information communications technology and sales, helping companies build roadmaps to deal with digital disruption.
  • He joins Gorilla from Aspen Technology, where he served as Vice President of Sales for Asia-Pacific and Japan.

Worksport Appoints First Plant Manager for New West Seneca, NY Manufacturing Facility

Retrieved on: 
Tuesday, August 30, 2022

Richmond Hill, Ontario, Canada, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Worksport Ltd. (Nasdaq: WKSP) (the Company or Worksport) has appointed as manager veteran manufacturing executive Michael Scolnick.

Key Points: 
  • Richmond Hill, Ontario, Canada, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Worksport Ltd. (Nasdaq: WKSP) (the Company or Worksport) has appointed as manager veteran manufacturing executive Michael Scolnick.
  • Scolnick has had over 25 years of progressive experience building and leading high-performance teams, developing and implementing world-class manufacturing concepts, and driving business performance.
  • ft. assembly plant, located in West Seneca, NY.
  • This is a turning point in Worksports history and one of the most significant hires we have announced, said Worksport CEO Steven Rossi.

New Platform Leverages Advanced Analytics to Surface Potential Adult Learners

Retrieved on: 
Thursday, July 21, 2022

WATERTOWN, Mass., July 21, 2022 /PRNewswire/ -- Liaison International, developer of the technology that has helped millions of students apply to academic programs at more than 1,000 colleges and universities over the last 30 years, today announced the release of a new analytics solution designed to help colleges and universities more effectively identify previously impossible to find adult learners. The new platform, called Intelligent Names, provides colleges and universities with a powerful new way to discover these sought-after potential students by leveraging scientific polling and advanced analytics.

Key Points: 
  • The new platform, called Intelligent Names, provides colleges and universities with a powerful new way to discover these sought-after potential students by leveraging scientific polling and advanced analytics.
  • More than two years since the pandemic began, colleges and universities continue to grapple with the effects of declining enrollment.
  • These declines are driven both by systemic changes like test-optional admissions, in addition to rapidly changing student demographics.
  • O'Brien believes that tapping into the power of predictive modeling and data science can help identify adult learners who are highly motivated to continue their educationbut have often been disconnected from higher education for long periods of time.

INNOVATE Corp. Announces Appointment of Brian Goldstein to the Board of Directors

Retrieved on: 
Wednesday, June 29, 2022

NEW YORK, June 29, 2022 (GLOBE NEWSWIRE) -- INNOVATE Corp. (INNOVATE or the Company) (NYSE: VATE), today announced the appointment of Brian Goldstein to fill a vacancy on the INNOVATE Board of Directors, effective immediately.

Key Points: 
  • NEW YORK, June 29, 2022 (GLOBE NEWSWIRE) -- INNOVATE Corp. (INNOVATE or the Company) (NYSE: VATE), today announced the appointment of Brian Goldstein to fill a vacancy on the INNOVATE Board of Directors, effective immediately.
  • I look forward to continuing to work with him as we execute on our strategic plan across our three operating segments.
  • INNOVATE also announced that it decreased the size of its Board of Directors to five members andis continuingtoidentify independent director candidates to filltheone remaining Board vacancy.
  • Following the appointment of Mr. Goldstein, the INNOVATE Board of Directors currently consists of four members, three of whom are independent.

New Data Demonstrates That Medela Outperforms Other Multi-Lumen Negative Pressure Wound Therapy (NPWT) Systems

Retrieved on: 
Tuesday, November 2, 2021

McHenry, IL, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Medela LLC today announced the release of new data in a white paper supplement to WOUNDS demonstrating the Medela Invia LibertyTM Negative Pressure Wound Therapy (NPWT) System outperforms other multi-lumen NPWT systems available in the market.

Key Points: 
  • McHenry, IL, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Medela LLC today announced the release of new data in a white paper supplement to WOUNDS demonstrating the Medela Invia LibertyTM Negative Pressure Wound Therapy (NPWT) System outperforms other multi-lumen NPWT systems available in the market.
  • To learn more about Medelas complete negative wound pressure therapy system, visit medelahealthcare.com or fill out the online form to receive information.
  • 1 Paglinawan R, Schwab P, Bechert K. Negative pressure wound therapy system Innovates standard of care via intelligent pressure control and dynamic exudate removal.
  • SAWC Fall 2020 Poster Number: LR-026; Poster Title: Novel Negative Pressure Wound Therapy (NPWT) System Provides Accurate Negative Pressure Delivery and Exceptional Fluid Handling Capability.

Kura Oncology Appoints Teresa Bair as Chief Legal Officer

Retrieved on: 
Monday, October 18, 2021

SAN DIEGO, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced the appointment of Teresa Bair as Chief Legal Officer and Corporate Secretary.

Key Points: 
  • SAN DIEGO, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced the appointment of Teresa Bair as Chief Legal Officer and Corporate Secretary.
  • Ms. Bair joins Kura with more than 25 years of combined in-house and law firm experience, most recently as General Counsel at Athenex.
  • On behalf of our board and senior leadership team, we want to extend a warm welcome to Teresa, said Troy Wilson, Ph.D., J.D., President and Chief Executive Officer of Kura Oncology.
  • Ms. Bair joins Kura from Athenex, where she served most recently as General Counsel and Senior Vice President, Administration.

Certara Appoints Patrick F. Smith to President of Integrated Drug Development

Retrieved on: 
Tuesday, October 12, 2021

as president of Integrated Drug Development (IDD), reporting to CEO William F. Feehery.

Key Points: 
  • as president of Integrated Drug Development (IDD), reporting to CEO William F. Feehery.
  • Dr. Smith will lead the Companys global drug development services team, which creates value for clients across the entire drug development life cycle using biosimulation and quantitative approaches.
  • Dr. Smith has worked across all phases of drug development with particular expertise in infectious diseases, oncology, and inflammation as well asnovel early development program design and applying modeling and simulation to solve critical development problems.
  • Certara accelerates medicines using proprietary biosimulation software and technology to transform traditional drug discovery and development.